Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

ObjectiveTo explore the efficacy of c in the multiline treatment of late-stage lung adenocarcinoma with Her-2 overexpression and epidermal growth factor receptor (EGFR) mutations.MethodsWe summarize the diagnosis and treatment of a female patient with EGFR 21L858R mutation combined with Her-2 overex...

Full description

Saved in:
Bibliographic Details
Main Authors: Meiling Lan, Tianyun Wang, Diexiao Luo, Yan Chen, Wei Liang, Rui Kong, Qichao Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
HER-2 overexpression
epidermal growth factor receptor
lung adenocarcinoma
disitamab vedotin
efficacy
multiline treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1472545/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items